Abterra Bio Has Moved To Sorrento Valley

In 2009, Abterra Bio began as Digital Proteomics LLC, a spin-out of the University of California – San Diego. Founders Pavel Pevzner and Vineet Bafna, as well as Natalie Castellana, Stefano Bonissone, and Anand Patel have been a part of Abterra’s story since its inception.

Our employees fine-tuned the technology for antibody sequencing and discovery, and as we started to hire more people, we outgrew our first location: a shared lab bench in a biotech start-up incubator. In 2020 with 6 employees, we moved to the San Diego Science Center, our first real office and lab that we could call our own. We invested in a Thermo Fisher Orbitrap Eclipse mass spectrometer to expand our throughput and add capabilities to our services to customers looking for antibody discovery, sequencing, and repertoire analysis. Throughout our time there, we continued to grow (See the Abterra team now), and eventually traded that office for yet another larger one.

Our current chapter has begun in our new Sorrento Valley office and we couldn’t be more excited. We’re enjoying our state-of-the-art lab, multiple floors of offices, and even a conference room! At first we wondered, “Is this too much?” but after some reflection, realized how hard we have worked to get here. We’ve already begun filling the lab with new equipment, including a new sequencer that quadruples our NGS sequencing throughput. Our new space provides the room to grow our team and our capabilities for our valued customers.
If you’re considering a project with us, we’d love to talk to you.

Related Posts
Customer Spotlight: Dr. Matthew Burchill
Dr. Burchill explains how Valens rescued his antibody and enabled him to continue his research. De novo antibody sequencing case study.
Multi-Species Antibody Repertoire Comparison
Abterra Bio uses Reptor’s antibody repertoire analysis workflow to compare and visualize antibodies from both naïve and immunized animals.
Abterra Biosciences is a unique CRO offering antibody sequencing and discovery services. We bring sophisticated algorithmic and machine learning approaches to enable accurate antibody sequencing and functional antibody discovery.
Tell Us About Your Project
Follow Abterra Bio On Social Media
More From Our Blog
Abterra Bio Seattle Angel Conference Winner
We’re excited to announce that Abterra Bio has been chosen as the Winner of the 19th Seattle Angel...
Digital Proteomics is Abterra Biosciences
We're excited to announce that Digital Proteomics is now Abterra Biosciences. Our vision for the...
We are a CONNECT Cool Company 2021!
We’re excited to announce that Abterra Biosciences has been selected as "A Cool Company" for the...